Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial
Abstract
Purpose:
We evaluated the efficacy of the web based P3P (Personal Patient Profile-Prostate) decision aid vs usual care with regard to decisional conflict in men with localized prostate cancer.
Materials and Methods:
A randomized (1:1), controlled, parallel group, nonblinded trial was performed in 4 regions of the United States. Eligible men had clinically localized prostate cancer and an upcoming consultation, and they spoke and read English or Spanish. Participants answered questionnaires to report decision making stage, personal characteristics, concerns and preferences plus baseline symptoms and decisional conflict. A randomization algorithm allocated participants to receive tailored education and communication coaching, generic teaching sheets and external websites plus a 1-page summary to clinicians (intervention) or the links plus materials provided in clinic (usual care). Conflict outcomes and the number of consultations were measured at 1 month. Univariate and multivariable models were used to analyze outcomes.
Results:
A total of 392 men were randomized, including 198 to intervention and 194 to usual care, of whom 152 and 153, respectively, returned 1-month outcomes. The mean ± SD 1-month decisional conflict scale (score range 0 to 100) was 10.9 ± 16.7 for intervention and 9.9 ± 18.0 for usual care. The multivariable model revealed significantly reduced conflict in the intervention group (–5.00, 95% CI –9.40––0.59). Other predictors of conflict included income, marital or partner status, decision status, number of consultations, clinical site and D’Amico risk classification.
Conclusions:
In this multicenter trial the decision aid significantly reduced decisional conflict. Other variables impacted conflict and modified the effect of the decision aid, notably risk classification, consultations and resources. P3P is an effective adjunct for shared decision making in men with localized prostate cancer.
References
- 1 : Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Linthicum: American Urological Association Education and Research2017. Google Scholar
- 2 : Trends in management for patients with localized prostate cancer, 1990-2013. JAMA2015; 314: 80. Google Scholar
- 3 : Use and predictors of expectant management of low and intermediate risk localized prostate cancer in elderly men. Urol Pract2017; 4: 132. Link, Google Scholar
- 4 : Variations in quality of care for men with early-stage prostate cancer. J Clin Oncol2008; 26: 3735. Google Scholar
- 5 : Perceptions of urologists about the conversational elements leading to treatment decision-making among newly diagnosed prostate cancer patients. J Cancer Educ2017; 32: 580. Google Scholar
- 6 : Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urol Oncol2003; 21: 93. Google Scholar
- 7 : Watching, waiting and uncertainty in prostate cancer. J Clin Nurs2007; 16: 734. Google Scholar
- 8 : Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer. Urology2004; 63: 751. Google Scholar
- 9 : The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial. Urol Oncol2013; 31: 1012. Google Scholar
- 10 : Factors that influence patient preferences for prostate cancer management options: a systematic review. Patient Prefer Adherence2015; 9: 899. Google Scholar
- 11 : The voice of the patient methodology: a novel mixed-methods approach to identifying treatment goals for men with prostate cancer. Patient2017; 10: 345. Google Scholar
- 12 : Physician recommendations trump patient preferences in prostate cancer treatment decisions. Med Decis Making2017; 37: 56. Google Scholar
- 13 : Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer. Patient Educ Couns2012; 88: 262. Google Scholar
- 14 : Usability testing the “Personal Patient Profile-Prostate” in a sample of African American and Hispanic men. Comput Inform Nurs2016; 34: 288. Google Scholar
- 15 : Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer. J Med Internet Res2010; 12: e67. Google Scholar
- 16 : User Manual-Decisional Conflict Scale, 2010. Available at http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decisional_Conflict.pdf. Accessed February 15, 2017. Google Scholar
- 17 : Usability evaluation and adaptation of the e-health Personal Patient Profile-Prostate decision aid for Spanish-speaking Latino men. BMC Med Inform Decis Mak2015; 15: 56. Google Scholar
- 18 : Patient education materials about the treatment of early-stage prostate cancer: a critical review. Ann Intern Med2004; 140: 721. Google Scholar
- 19 : Validity of a low literacy version of the Decisional Conflict Scale. Patient Educ Couns2011; 85: 521. Google Scholar
- 20 : The changing face of prostate cancer. J Clin Oncol2005; 23: 8146. Google Scholar
- 21 : a decision aid to support informed choices for patients recently diagnosed with prostate cancer: a randomized controlled trial. Cancer Nurs2015; 38: E42. Google Scholar
- 22 : Integrating patient preference into treatment decisions for men with prostate cancer at the point of care. J Urol2016; 196: 1640. Link, Google Scholar
- 23 : Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial. Patient Educ Couns2009; 77: 349. Google Scholar
- 24 : The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial. Med Decis Making2012; 32: 616. Google Scholar
- 25 : When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer. Health Qual Life Outcomes2014; 12: 159. Google Scholar
- 26 : Comparison of patient reported quality of life outcome questionnaire response rates between patients treated surgically for renal cell carcinoma and prostate carcinoma. BMC Urol2015; 15: 58. Google Scholar
